Can-Fite BioPharma Secures Eurasian Patent for Piclidenoson
Can-Fite BioPharma has announced a patent allowance for Piclidenoson, enhancing its position in the pharmaceutical market for rare diseases.
Kamada to Announce Third Quarter Financial Results on Nov. 9
Kamada Ltd. will release its Q3 financial results on November 9, 2026, with a conference call to discuss the outcomes. Watch for industry impacts.
TAT Technologies Reports Strong Q3 2026 Financial Results
TAT Technologies Ltd. announces significant revenue and net income growth in Q3 2026, indicating strong performance in the aircraft engines sector.
RedHill Biopharma confirms RHB-204 efficacy for Crohn's disease
RedHill Biopharma Ltd. confirms RHB-204's efficacy against Crohn's disease, enhancing treatment options in the pharmaceutical industry.
Marriott International Reports Third Quarter 2026 Results
Marriott International reports strong Q3 2026 results with RevPAR growth, showcasing resilience in the Hotels & Motels industry.
Tempus AI Reports Q3 Results, Shows Revenue Growth
Tempus AI, Inc. announces Q3 financial results, highlighting significant revenue growth and strategic partnerships in the computer programming sector.
Tempus AI, Inc. Reports Q3 2026 Financial Results
Tempus AI, Inc. announces its financial results for Q3 2026, showcasing growth and potential impacts on the tech industry.
Eton Pharmaceuticals Launches ET-900 Program for Spasms
Eton Pharmaceuticals announces ET-900, a new program for treating infantile and epileptic spasms, in collaboration with Baylor College of Medicine.
Information Services Group reports Q3 2026 earnings results
Information Services Group Inc. releases its Q3 2026 earnings, discussing financial performance and future strategies in the management consulting services sector.
Vertical Data Inc. estimates Q3 revenue, plans private placement
Vertical Data Inc. projects Q3 2026 revenue of $0.4-$0.5 million and plans a $4.2 million private placement, signaling growth in management consulting.
Seaport Therapeutics Reports Q3 2026 Financial Results
Seaport Therapeutics, Inc. announces its financial results for Q3 2026, impacting the pharmaceutical preparations industry and influencing stakeholder decisions.
Alpine Income Property Trust Completes $117.3M Acquisition
Alpine Income Property Trust, Inc. has acquired a 13-property industrial portfolio for $117.3 million, enhancing its market position in the real estate sector.
Citigroup Global Markets files preliminary term sheet for new product
Citigroup Global Markets Holdings Inc. files a preliminary term sheet for a new financial product linked to S&P 500 Futures, expanding its offerings.
Citigroup files for new securities linked to S&P 500
Citigroup Inc. has filed a preliminary pricing supplement for new securities linked to the S&P 500, aiming to diversify its financial offerings.
Accendra Health amends receivables securitization program
Accendra Health Inc. extends its receivables securitization program to 2029, signaling a strategic move to enhance liquidity and financial management.
GraniteShares ETF Trust Delays Effectiveness of Amendment
GraniteShares ETF Trust has filed to delay the effectiveness of its amendment for the GraniteShares 3D Stacked AI Chips ETF, impacting the ETF market.
GraniteShares delays effectiveness of AI Energy ETF filing
GraniteShares ETF Trust delays the effectiveness of its registration statement for the AI Energy ETF until November 6, 2026, impacting the investment sector.
GraniteShares Delays GraniteShares Defense AI ETF Launch
GraniteShares ETF Trust delays the launch of its GraniteShares Defense AI ETF until November 6, 2026, reflecting ongoing compliance efforts.
GraniteShares ETF Trust files amendment for Data Center Cooling ETF
GraniteShares ETF Trust extends its Data Center Cooling ETF registration until November 6, 2026, emphasizing regulatory compliance in the ETF sector.
GraniteShares ETF Trust Delays Effectiveness of Registration
GraniteShares ETF Trust files to delay effectiveness of its registration statement for the GraniteShares Orbital AI ETF until November 6, 2026.